SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000929638-15-000355
Filing Date
2015-03-23
Accepted
2015-03-23 16:05:33
Documents
2
Group Members
BIHUA CHENCORMORANT ASSET MANAGEMENT LLCCORMORANT GLOBAL HEALTHCARE GP LLCCORMORANT GLOBAL HEALTHCARE MASTER FUND LP

Document Format Files

Seq Description Document Type Size
1 a68217_sc13g.htm SC 13G 141933
2 JOINT FILING AGREEMENT a68217_exhibit1.htm EX-1 12559
  Complete submission text file 0000929638-15-000355.txt   156288
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Subject) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88022 | Film No.: 15719258
SIC: 2834 Pharmaceutical Preparations

Mailing Address 100 HIGH STREET SUITE 1105 BOSTON DC 02110
Business Address 100 HIGH STREET SUITE 1105 BOSTON DC 02110 617-848-3429
Cormorant Global Healthcare Master Fund, LP (Filed by) CIK: 0001618442 (see all company filings)

IRS No.: 981101801 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G